About: Amy Y. Gu, Managing Editor
Amy Y. Gu, J.D. is the Managing Editor for the Source on Healthcare Price & Competition. She holds a J.D. from Loyola Law School and a B.A. in Economics from the University of California, Berkeley. Prior to joining the Source, she practiced civil litigation in the San Francisco Bay Area, and later engaged in corporate compliance and discovery, representing various global pharmaceutical companies. Driven by an entrepreneurial mindset and her talents for marketing and web design, Amy also co-founded and successfully launched a startup in e-commerce. She is excited to bring to the Source a unique set of experience and perspective from both law and tech.Introducing the New Interactive Key Issue Page: Market Consolidation
Amy Y. Gu, Managing Editor December 4, 2019
The Source on Healthcare Price and Competition is excited to announce that, in partnership with UC Berkeley’s Nicholas C. Petris Center on Health Care Markets and Consumer Welfare, we are unveiling a brand new interactive “Market Consolidation” key issue page that presents evidence-based information and analyses on the most effective strategies for states to address rapidly consolidating healthcare markets. Recent evidence demonstrates that provider and insurer markets in the United States have been highly concentrated for years and have led to increased healthcare prices and insurance premiums without a commensurate …
Legal Challenges Against State PBM Laws May Culminate in Supreme Court Review
Amy Y. Gu, Managing Editor November 15, 2019
As states step up their efforts to control prescription drug prices, many state legislatures have targeted pharmacy benefit managers (PBMs) and their role in rising prices by introducing legislation to bring greater transparency to the inner workings of PBMs. As a result of these efforts, however, states increasingly face challenges from the pharmaceutical industry, specifically the Pharmaceutical Care Management Association (PCMA), a trade association representing PBMs. Over the years, PCMA has brought a number of lawsuits challenging state legislation regulating PBMs, claiming that the Employee Retirement Income Security Act (ERISA) …
[Sutter Case Watch] Source Executive Editor Jaime King Discusses Sutter Health Settlement in Podcast
Amy Y. Gu, Managing Editor October 30, 2019
As the healthcare industry grapples with the recent settlement of the antitrust case against Sutter Health, The Source Executive Editor Jaime King discusses the possible motivations and implications of this development in Tradeoffs, a healthcare podcast. In Episode 2 of the podcast, The Train Has Left the Station, Professor King points out that because Sutter is a model for many other health systems around the country, the lawsuit against Sutter’s contracting practices, including all or nothing provisions, had the potential to send shockwaves through the system. The actual implications of …
[Sutter Case Watch] BREAKING: Sutter Health Settles Massive Antitrust Suit to Avoid Trial
Amy Y. Gu, Managing Editor October 16, 2019
The historic court case against Sutter Health alleging anticompetitive contract practices took an unexpected turn today when Judge Anne-Christine Massullo of the Superior Court of San Francisco dismissed the jury, announcing that Sutter has reached a preliminary settlement with the California AG and class action plaintiffs. Opening arguments in the case were set for October 21, after it was delayed from October 10 due to an insufficient number of jurors. The trial was estimated to last about 12 weeks and would have put the spotlight on the details of Sutter …
[Case Watch] Jury Trial in Antitrust Case Against Sutter Health Set to Begin
Amy Y. Gu, Managing Editor October 9, 2019
The landmark antitrust case against Sutter Health, the largest provider of general acute hospital services in Northern California, is set to begin jury trial in the Superior Court of San Francisco on October 10 and is expected to last 12 weeks. The trial will begin at 10:15am with opening arguments from both parties. The Source has been closely tracking this case leading up to the trial. Executive Editor Jaime King was quoted in multiple news outlets, including the New York Times, San Francisco Chronicle, and Bloomberg Law, regarding the ripple …
[Case Watch] UCFW & Employers Benefit Trust v. Sutter Health] A Look at the Legal Arguments Through the Lens of the Court’s Denial of Sutter’s Motions for Summary Judgment
Amy Y. Gu, Managing Editor October 7, 2019
As part of the Case Watch series for the landmark antitrust suit against Sutter Health, this post takes a look back at the Superior Court of San Francisco’s orders from March and June 2019, denying Sutter’s motions for summary judgment, which set the stage for the jury trial, set to begin on Thursday, October 10, 2019. As a preview of the legal arguments we will see at trial, we dissect each of the four causes of action brought against Sutter in the context of Sutter’s motions and the court’s rulings. …
Just Published: The Source Research Brief on Legal Challenges to State Efforts to Control Drug Prices
Amy Y. Gu, Managing Editor September 24, 2019
As states increase legislative efforts to rein in prescription drug prices, an increased number of laws have been passed to regulate pharmacy benefit managers, price gouging, and price transparency in the pharmaceutical industry. However, industry groups have also stepped up legal challenges against these laws, using specifically the Dormant Commerce Clause, ERISA, and federal patent and trade secret laws. With support from the National Academy for State Health Policy (NASHP), The Source’s Katie Gudiksen, Sammy Chang, and Jaime King examine these state laws and ensuing legal challenges in the newly …
[Case Watch] Commonwealth of Pennsylvania v. UPMC and Highmark: State AG Prevails with 10-Year Consent Decree After Long Bitter Court Battle
Amy Y. Gu, Managing Editor September 16, 2019
Pennsylvania’s efforts to restore competition to the provider and insurance markets in the long-standing battle between University of Pittsburgh Medical Center (UPMC) and Highmark Health overcame mounting challenges and finally concluded with an unprecedented 10-year consent decree. The Source closely tracked the case as it unfolded over the past several months. In this post, we take a look back at the case’s long and winding road, which included three stops at the Pennsylvania Supreme Court, leading up to the new truce. It’s Déjà Vu All Over Again It all began in …
Health Affairs Blog Highlights The SLIHCQ Database
Amy Y. Gu, Managing Editor August 22, 2019
Hot off the press: Health Affairs Blog post The State Of State Legislation Addressing Health Care Costs And Quality highlights The State Laws Impacting Healthcare Cost (SLIHCQ) Database established by The Source on Healthcare Price and Competition and Catalyst for Payment Reform (CPR). The Source Executive Editor Jaime King and CPR Director Suzanne Delbanco discuss key approaches states are taking to develop high-quality, affordable health care, including transparency laws, payment reform and benefit design laws, laws that encourage provider competition, and laws that govern oversight and regulation of costs. Check …
Introducing “Wall Street Perspective” on The Source Blog
Amy Y. Gu, Managing Editor July 25, 2019
The Source Blog is launching a new op-ed column, Wall Street Perspective, headlined by The Source Health Policy Research Fellow, Gary Ko. As a former Healthcare Equity Research Analyst for one of the largest Mutual Fund Companies in the world, Gary provides a unique economic perspective on issues facing the U.S. health care system. We hope this column will facilitate a general discussion of health system reform and invite our readers to share their opinions and questions, particularly on topics of healthcare economics and corporate finance. Check out the inaugural post …